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Background. It is recognized that the ability of adipose tissue to expand in response to energy excess, i.e. adipocyte
maturation, is important in determining systemic abnormalities in glucose and lipid metabolism. Ectonucleotide pyropho-
sphatase phosphodiesterase 1 (ENPP1, also known as PC-1) has been recently reported to be involved in the pathogenesis of
insulin resistance and related diseases. However, its role on adipose tissue physiology as a mechanism of systemic insulin
resistance is not understood. This study was performed to evaluate whether ENPP1 is regulated during adipogenesis and
whether over-expression in adipocytes can affect adipocyte maturation, a potential novel mechanism of ENPP1-related insulin
resistance. Methodology/Principal Findings. ENPP1 expression was found down-regulated during 3T3-L1 maturation, and
over-expression of human ENPP1 in 3T3-L1 (pQCXIP-ENPP1 vector) resulted in adipocyte insulin resistance and in defective
adipocyte maturation. Adipocyte maturation was more efficient in mesenchymal embryonal cells from ENPP1 knockout mice
than from wild-type. Conclusions. We identify ENPP1 as a novel mechanism of defective adipocyte maturation. This
mechanism could contribute to the pathogenesis of insulin resistance in absence of obesity.
Citation: Liang J, Fu M, Ciociola E, Chandalia M, Abate N (2007) Role of ENPP1 on Adipocyte Maturation. PLoS ONE 2(9): e882. doi:10.1371/
journal.pone.0000882
INTRODUCTION
The primary function of adipose tissue is to store energy in the
form of triglycerides during periods of excessive energy intake.
Adipocyte hypertrophy and hyperplasia are physiologic responses
to energy excess that, if protracted, determine onset of obesity.
This process often associates with abnormal adipose tissue function
so that further triglyceride storage becomes inefficient. Conse-
quent changes in plasma adipokine concentrations have the effect
of modifying glucose and lipid metabolism in various tissues and
organs [1]. This contributes to the clustering of metabolic
abnormalities typically found in patients with the metabolic
syndrome [2]. One important aspect of adipose tissue dysfunction
is increased fatty acid spillover in the bloodstream [3], a condition
that negatively impacts insulin-mediated glucose disposal in
skeletal muscle [4]. This results in susceptibility to insulin
resistance and its associated complications [5].
It has become increasingly recognized that the ability of adipose
tissue to expand in response to energy excess, i.e. adipocyte
maturation, is important in determining systemic abnormalities in
glucose and lipid metabolism. For example, patients with
lipodystrophy are unable to store even small amount of
triglycerides due to either total or partial absence of adipose tissue
[6]. Excessive caloric intake in these patients translates into high
plasma non-esterified fatty acids (NEFA), increased triglyceride
storage in lean tissues, severe insulin resistance and type 2 diabetes.
This condition has been observed to a lesser degree also in the so
called ‘‘metabolically obese lean persons’’ [7,8]. It is possible that
metabolically obese lean persons are unable to respond to caloric
excess by increasing adipocyte maturation. Defective adipocyte
maturation would then lead to excessive plasma NEFA and insulin
resistance at lower body mass index (BMI). On the other hand,
adipocyte maturation induced by thiazolindiones often resolves
abnormalities in lipid and glucose metabolism. Therefore, un-
derstanding the role played by mediators of adipocyte maturation
could provide important insight into the pathogenesis of insulin
resistance in the absence of overt obesity.
It has been previously reported that the transmembrane
glycoprotein ectonucleotide pyrophosphatase phosphodiesterase
1 (ENPP1; also known as plasma cell membrane glycoprotein PC-
1) could be mechanistically linked to insulin resistance [9]. ENPP1
interacts with the insulin receptor and inhibits subsequent
signaling by decreasing its [beta] -subunit autophosphorylation
[10–11]. We have found that ENPP1 K121Q, a common genetic
polymorphism that determines increased ENPP1-insulin receptor
interaction, can be associated with insulin resistance in absence of
obesity [12]. In fact, we have also observed that ENPP1 K121Q is
associated with lower BMI in a recessive model [13]. Since ENPP1
is abundantly expressed in adipose tissue [14] and, since insulin
plays a role on adipocyte maturation [15], the possibility of
ENPP1-mediated defect in adipose tissue ability to expand in the
presence of caloric excess should be considered as a mechanism of
systemic insulin resistance. In the present study we evaluated the
role of ENPP1 in determining adipocyte maturation defect.
METHODS
Cell culture and differentiation
3T3-L1 preadipocytes were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum, 100 U/ml penicillin, 100 mg/ml streptomycin in a 5%
CO2 humidified atmosphere and allowed to reach confluence.
Differentiation of two-day post-confluent preadipocytes was
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3-iso-butyl-1-methylxanthine in DMEM supplemented with 10%
fetal bovine serum. The culture medium was replaced every 48 h
with DMEM supplemented with 10% fetal bovine serum and
5 mg/ml insulin.
ENPP1 transfection
Human ENPP1 K121K and ENPP1 K121Q were transfected in
3T3-L1 using a pQCXIP-ENPP1 vector. Both vector and ENPP1
cells were then exposed to puromycin (2.5 mg/mL) for 7 days.
Contaminated cells were eliminated.
Oil Red O staining
Cells were washed twice with PBS and fixed with 10% formalin in
PBS for 15 min. After two washes in PBS, cells were stained for at
least 1 h in freshly diluted Oil Red O solution (six parts Oil Red O
stock solution and four parts H2O; Oil Red O stock solution is
0.5% Oil Red O in isopropanol). The stain was then removed and
the cells were washed twice with water, with or without
counterstain (0.25% giemsa for 15 min) and then photographed.
Triglyceride quantification in cultured cells
When cells in 96-well plates were 100% confluent, the culture
supernatant was removed and each well rinsed with 200 ul of
phosphate-buffered saline (PBS). Each well was filled with 200 ul
of room temperature PBS. 5 ul of Adipored reagent (Cambrex
Bioscience Walkersville, Inc.) were added to each well of the plate.
Fluorescence with excitation at 485 nm and emission at 572 nm
was measured to calculate triglyceride content.
Cell death measurement
Cell death ratio was quantified by trypan blue assay. After washing
with PBS, cell cultures were immediately stained with 0.4% trypan
blue for 10 min, fixed with formalin, and rinsed with physiological
saline. Unstained cells were regarded as viable and stained cells
were regarded as dead. The viability of the cultures was calculated
as the percentage ratio of the number of unstained cells relative to
the total cells counted. Over 200 cells per cover slip were
randomly counted.
Glucose uptake Assay
3T3-L1 adipocytes were seeded in 6-well plates. Cells were serum
starved for 3 h before the assay. Cells were then washed twice with
KRPH buffer (5 mM Na2HPO4, 20 mM HEPES, pH 7.4, 1 mM
MgSO4, 1 mM CaCl2, 136 mM NaCl, 4.7 mM KCl, 0.1% [wt/
vol] BSA) and stimulated with 100 nM insulin or left untreated for
30 min. Glucose uptake was measured by incubation with 0.1 mM
2-deoxyglucose containing 1 mCi/ml 2-deoxy-d-glucose, [U-
14C]
at 4uC for 5 min. Transport was terminated by washing the cells
three times with ice-cold PBS. Cells were solubilized with 0.2 mol/
L NaOH, and the radioactivity was detected by scintillation
counting. Nonspecific deoxyglucose uptake was measured in the
presence of 20 mM cytochalasin B and was subtracted from each
determination to obtain specific uptake.
Figure 1. Expression of ENPP1 decreases in the early maturation phase of 3T3-L1 into adipocytes. 3T3-L1 cells were induced to differentiate into
adipocytes by desamethasone, 3-iso-butyl-1-methylxanthine and insulin (DMI). The RNA was isolated at different time points, as indicated. Data show
real time PCR for expression of ENPP1 and other genes involved in adipocyte maturation. Mean and SD from 3 experiments are presented in arbitrary
units after correction for 18S expression. One-way ANOVA p-value for multiple group comparison was ,0.05 for each of the gene expression data
shown in figure. Pre-adipocyte are shown as dark bars, mature adipocyte are shown as open bars
doi:10.1371/journal.pone.0000882.g001
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Tissue was homogenized with a Potter-Elvehjem pestle in Cell Lysis
Buffer (Cell Signaling Technology, Danvers, MA). Proteins were
separated by SDS-PAGE, transferred to a nitrocellulose membrane
(Bio-Rad), and incubated overnight with the antibody. Phospho-
InsulinReceptorantibody(SigmaAldrich),InsulinReceptorantibody
(BD Bioscience, San Jose, CA), and human ENPP1 antibody
(Imgenex Corp. San Diego, CA) were commercially available.
Figure 2. Human ENPP1 over-expression inhibits DMI-induced adipocyte maturation in 3T3-L1 cells. Human ENPP1 was over-expressed in 3T3-L1
using retrovirus transfection with CMV promoter. Panel A. ENPP1 protein content in cells containing vector only and in cells over-expressing human
ENPP1 K121K or K121Q. ENPP1 was identified at 130 kDa using antibody from Imegex Corp. (San Diego, CA). Panel B. Oil-red-O stained 3T3-L1 cells
after induction of adipogenesis. Cells were 100% confluent at the time of assay. Cellular triglyceride content is presented as fold changes from the
triglyceride content of cells containing vector. Results are reported as mean and SD from measurements performed three times (8 wells measured in
each experiment). Panel C. Cells were plated on 6-well plate and induced to differentiation with DMI. At different days, as indicated, the cell number
was counted. Results are reported as mean and SD from measurements repeated three times (3 wells measured in each experiment). Open squares
represent the data for the vector 3T3-L1. Open circles represent the data for 3T3-L1 over-expressing human ENPP1 K121K. Dark circles represent the
data for 3T3-L1 over-expressing human ENPP1 K121Q. Cell death was measured at day 2 and day 4 of differentiation with DMI. Results are shown as
mean and SD of percentage of dead cells relative to total cells. Measurements were performed for number of viable and dead cells in three wells for
each cell type. These experiments were repeated 3 times. * p,0.05 for t-test between 3T3-L1 over-expressing human ENPP1 K121K and the vector
group. { p,0.05 for t-test between 3T3-L1 over-expressing human ENPP1 K121Q and the vector group.
doi:10.1371/journal.pone.0000882.g002
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Embrional cells (EF) cells were isolated from ENPP1 knockout
(KO) mice embryos [16] at day 13 or 14 of gestation. Isolated
embryos were place into dish with PBS and dissected to remove
the head and soft tissue (liver, intestine, kidney, lung, heart).
Embryo carcasses were placed into 10 cm dish and minced into
fine pieces in trypsin/EDTA. Cell suspension was placed into
T165 flask in EF medium and frozen after reaching confluence.
mRNA Quantification
Total RNA was isolated from frozen tissues using RNA STAT-60
(Tel-Test, Friendswood, TX). Genomic DNA was removed from
the total RNA preparations using DNAse 1 (DNA Free, Ambion).
RNA from each sample was diluted to 5mng/ml and 100 ng RNA
reverse transcribed in a 100 ml reaction using random hexamers
(TaqMan Reverse Transcription kit, Applied Biosystems). To
produce cDNA for standard curves, RNA from each of the control
samples was pooled and serially diluted before cDNA synthesis.
Each PCR reaction contained 2 ml cDNA, 150 nM each of
forward and reverse primers, and 5 ml SYBR Green Universal
PCR Master Mix (Applied Biosystems). Thermal cycling and data
collection were performed using the ABI Prism 7900HT in-
strument (Applied Biosystems). Data were analyzed using SDS
v2.2 software (Applied Biosystems). Relative quantification of gene
expression was by the comparative CT method (User Bulletin #2,
Applied Biosystems). 18S mRNA was the endogenous control for
total RNA content. Primers were designed using Primer Express
v2.0 (Applied Biosystems) and synthesized by Integrated DNA
Technologies. Amplification efficiency of each primer set was
determined by analyzing the slope of the standard curve (User
Bulletin #2, Applied Biosystems).
Statistics
Data are presented as mean6SD and were analyzed by 2-tailed
Student’s t test. One-way ANOVA was performed for multiple
independent group comparisons (figure 1). Statistical analysis was
performed using SAS version 8.02 (SAS Institute, Cary, NC).
RESULTS
Studies in 3T3-L1 showed that ENPP1 expression is decreased
during adipogenesis. Figure 1 shows the results on changes in
ENPP1 gene expression during the differentiation process of 3T3-
L1 cells. We used quantitative PCR analysis in 3T3-L1 cells
exposed to differentiation media containing dexamethasone, 3-iso-
butyl-1-methylxanthine and insulin (DMI). ENPP1 expression was
significantly increased during the first 16 hrs of DMI-induced
adipogenesis. However, its expression significantly decreased after
the first day of adipocyte differentiation. This was associated with
similar changes in expression of C/EBP-b a factor known to play
a central role in adipocyte differentiation [17]. Gradual adipocyte
maturation was coupled with increased expression of PPAR-U,
adipsin, aP2, SREBP1c, genes that are also known to be regulated
during the adipocyte differentiation process [18,19].
The coordinated changes in expression of ENPP1 and
adipogenetic molecules suggest a role of ENPP1 in adipocyte
maturation. To explore this possibility we generated 3T3-L1 over-
expressing both human ENPP1 K121K and ENPP1 K121Q, using
a pQCXIP-ENPP1 vector. As shown in Figure 2, antibody against
ENPP1 could detect high protein content in the cells over-
expressing both forms of ENPP1 but not in the vector cells.
Maturation of adipocytes was decreased in 3T3-L1 over-expres-
sing both types of ENPP1. Cells containing either K121K or
K121Q genotypes had significant reduction in triglyceride
content, as compared to the vector cells. Cell growth was
significantly decreased in 3T3-L1 over-expressing human ENPP1
K121K and K121Q. On the other hand, cell death was not found to
be different in the three different cell lines.
To evaluate whether the inhibitory effects of ENNP1 over-
expression in 3T3-L1 cells associates also with a change in
expression of genes involved in adipogenesis, we measured gene
expression in the three cell lines, using QPCR approach. As shown
in figure 3, over-expression of ENPP1 K121K or K121Q was
associated with decreased expression of PPAR-U, C/EBP-b, adipsin,
SREBP1c, and aP2 at 10 days of DMI-induced differentiation.
To verify whether ENPP1 over-expression associates with
defective activation of insulin receptor, we measured both total
and phosphorylated insulin receptor in vector cells and in cells
over-expressing the K121K and K121Q forms of ENPP1 following
insulin stimulation (5 mg/mL of insulin for 15 minutes). As
expected, insulin receptor phosphorylation was significantly
decreased in the cells over-expressing human ENPP1 (Figure 4,
Panel A). Downstream insulin-mediated Akt phosphorylation was
also decreased in cells over-expressing ENPP1 (Figure 4, Panel B).
Glucose uptake in the presence of insulin was decreased in cells
over-expressing ENPP1 (Figure 4, Panel C).
To further confirm a role of ENPP1 regulation on adipogenesis,
we studied mouse embryonic fibroblasts (MEF) of ENPP1
Figure 3. Human ENPP1 K121K and K121Q over-expression induce
changes in the expression of genes present of 3T3-L1 induced to
maturation. The expression levels of several adipogenic markers in
vector only, in ENPP1 K121K and ENPP1 K121Q stable cell lines 10 days
after DMI induction were measured by QPCR and normalized by the
level of 18S. Experiments were repeated 3 times. The average values
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adipocyte maturation was more effective in MEF from ENPP1
knockout mice than in MEF from wild-type mice. These effects on
adipocyte maturation were seen in concomitance not only to an
absent expression of ENPP1 but also to significantly increased
expression of adipsin, SREBP1c, PPAR-U, C/EBP-b and aP2 gene
expression in the ENPP1 knockout adipocytes (Panel B of Figure 5).
DISCUSSION
The main finding of this study is that ENPP1 expression is involved
in regulation of adipocyte maturation, a mechanism that may
contribute to systemic fatty acid and glucose metabolism
maintenance during weight gain. We first found that ENPP1 is
highly regulated during adipogenesis. We also found that its
increased interaction with the insulin receptor not only associates
with defective cellular insulin signaling, as previously described
[9,10], but also with defective adipocyte maturation.
Previous investigations have suggested that ENPP1 over-
expression specifically induces defective insulin signaling in cells
[20]. This effect has also been observed with the common ENPP1
K121Q genetic variant, and attributed to a stronger interaction
between the non-catalytic domains of the mutated ENPP1 with
the insulin receptor [11]. Consequent reduction in insulin
signaling transduction from the a- to the b-subunit of the insulin
receptor would reduce the ability of insulin to stimulate
downstream signaling cascade. According to this view, ENPP1
over-expression in liver and muscle, two main tissues involved in
insulin-mediated regulation of glucose and lipid metabolism,
determines insulin resistance and susceptibility to type 2 diabetes.
Recent animal models over-expressing ENPP1 in liver and in other
tissues, including muscle, have shown insulin resistant phenotype
[21,22]. However, these animal models have not included ENPP1
over-expression in adipose tissue. The possibility that ENPP1,
would impact glucose and lipid metabolism through an effect on
Figure 4. Human ENPP1 K121K and K121Q over-expression induce insulin resistance in 3T3-L1 cells. Panels A and B-Cells were treated with 5 mg/
ml of insulin for 15 minutes. Total and phosporylated insulin receptor Akt were determined by Western Blot. Results are shown as bar graph of the
ratio between phosphorylated and total insulin receptor. Phosphorylated Akt was determined by western blot. The quantitative values of the bands
are shown beside the western blot image for 3 separate experiments. Panel C-3T3-L1 adipocytes were seeded in 6-well plates. Cells were stimulated
with 100 nM and glucose uptake measured by incubation with 0.1 mM 2-deoxyglucose containing 1 mCi/ml 2-deoxy-d-glucose, [U-
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to be of importance in light of the high expression of ENPP1 in
human adipose tissue [14] and in light of the role that adipose
tissue function plays in the pathogenesis of systemic insulin
resistance and type 2 diabetes. In addition, we have recently
shown an interaction between ENPP1 121Q variant and BMI in
humans in predicting insulin resistance [12] and type 2 diabetes
[23]. In those studies we have suggested that lack of inclusion of
this variable may contribute to the apparent discrepancy among
published genetic association studies on ENPP1 K121Q and type 2
diabetes. Although previous studies in 3T3-L1 have failed to detect
effects of ENPP1 over-expression on cellular insulin sensitivity [24],
our results show that ENPP1 over-expression can impair insulin
receptor activation in 3T3-L1 cells (figure 4). This apparent
discrepancy could be related to the different approach used to
obtain ENPP1 over-expression in 3T3-L1. We used a pQCXIP-
ENPP1 vector to obtain stable transfected cell lines, as opposed to
the adenovirus system used in the study by Sakoda et al. [24].
A novel finding of our study is that ENPP1 is highly regulated
during adipogenesis. Although we did not address the mechanistic
details of ENPP1 regulation, we determined that ENPP1 expression
is coordinated with changes in expression of genes that are known
to be involved in the adipocyte maturation progress (Figure 2) [17–
19]. We also show that over-expression of ENPP1 in transfected
3T3-L1 cells will affect maturation process in association with
decreased insulin-mediated activation of insulin receptor and with
insulin-mediated glucose uptake. Insulin increases the percentage
of cells that differentiate, and also increases the amount of lipid
accumulation in each fat cell [15]. Although other mechanisms
mediating ENPP1 effect on adipogenesis cannot be excluded, the
possibility exists that interference with insulin receptor function
plays a role in modulation of adipocyte maturation. Therefore, the
results of our study support the new hypothesis that inheritance of
the common genetic variant ENPP1 K121Q, a gain of function on
the ENPP1-induced insulin receptor inhibition [10], would
predispose individuals to decreased ability in forming mature
adipocyte when storage of excessive energy intake is needed. As
a consequence, decreased fatty acid uptake by adipocytes and/or
excessive lipolysis could cause high plasma NEFA concentrations,
hyperinsulinemia and defective insulin-mediated glucose utiliza-
tion in skeletal muscle. ENPP1 K121Q has been previously
associated with human obesity [14]. On the other hand, whether
this association was related to coexisting confounding factors, such
as diabetes, is not clear. In fact, other studies have suggested an
association with decreased body mass index (BMI) [13,25].
Clearly, mechanisms for adipogenesis and onset of obesity are
complex, and alternative pathways can compensate for the
inhibitory effects of ENPP1 on adipogenesis. Regardless, the
effects of increased ENPP1 expression on adipocyte maturation
could have a negative influence on the overall adipose tissue ability
to compensate for excessive caloric intake and maintain normal
systemic glucose and lipid metabolism.
The results of our study and the high frequency of ENPP1
K121Q in humans [26] support the view that among the various
described mechanisms of insulin resistance mediated by defective
adipogenesis, such as in lipodystrophy models [27,28], in defective
PPAR-c function [29], and in Pref-1 overproduction [30], ENPP1
expression and its K121Q variant are likely to explain a large
portion of the ‘‘garden variety’’ insulin resistance we find in people
at relatively low body mass index (BMI). ENPP1 K121Q could be
an important determinant of genetic susceptibility to insulin
resistance and may provide a useful clinical marker and
a therapeutic target for insulin resistance, type 2 diabetes and
cardiovascular disease.
In summary, the results of our studies support a role of increased
ENPP1 expression in the pathogenesis of insulin resistance in
humans. In addition to previously proposed mechanisms of systemic
insulin resistance mediated by effects of ENPP1 on cellular insulin
function in hepatocyte and myocyte, we suggest that its effect on
glucose metabolism is, at least in part, mechanistically linked to
ENPP1-induced inhibition of adipocyte maturation. Defective
adipocyte maturation related to increased ENPP1 function does
not exclude the possibility of obesity [14]. However, it may
contribute to earlier onset of insulin resistance and related
morbidities even with modest body fat increase [12,23].
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Figure 5. Adipocyte differentiation is enhanced in the absence of
ENPP1. Panel A. Oil-red-O stained mouse embrionic fibroblasts (MEF)
from ENPP1 knockout mice after induction of adipogenesis using
stimulation with DMI. Cellular triglyceride content is presented as fold
changes from the triglyceride content of cells containing vector. Results
are reported as mean and SD from three experiments (8 wells were
analyzed in each experiment). Panel B. The expression levels of several
adipogenic markers in differentiated wild-type and ENPP1 knockout
MEFs were measured by QPCR and normalized by the level of 18S.
Experiments were repeated 3 times.
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